Skip to main content
Figure 2 | Arthritis Research & Therapy

Figure 2

From: Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus

Figure 2

Influence of induction therapy with mycophenolate mofetil (MMF) and cyclophosphamide (CYC) on free light chain (FLC) levels. Levels of free kappa light chains (FLCkappa) (A) and free lambda light chains (FLClambda) (C) prior to and approximately 16 and 31 weeks after start of induction therapy with MMF. Levels of free kappa light chains (FLCkappa) (B) and free lambda light chains (FLClambda) (D) prior to and approximately 15 weeks after start of induction therapy with CYC. Statistical analyses were performed using the Wilcoxon’s matched pairs signed rank test and P-values <0.05 were considered significant.

Back to article page